{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:28:38Z","timestamp":1791347318766,"version":"4.3.1"},"reference-count":14,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T00:00:00Z","timestamp":1331078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032173","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T22:00:49Z","timestamp":1331157649000},"page":"e32173","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Safety, Effectiveness and Concentrations of Adjusted Lopinavir\/Ritonavir in HIV-Infected Adults on Rifampicin-Based Antitubercular Therapy"],"prefix":"10.1371","volume":"7","author":[{"given":"Eric H.","family":"Decloedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepta","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funeka","family":"Bango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,7]]},"reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.","volume":"Aug 24;23","author":"SD Lawn","year":"2009","journal-title":"AIDS"},{"key":"ref2","article-title":"Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis.","year":"2007"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.48.5.1553-1560.2004","article-title":"Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.","volume":"May;48","author":"CJ la Porte","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1128\/AAC.01598-10","article-title":"Pharmacokinetics of Lopinavir in HIV-Infected Adults Receiving Rifampin with Adjusted Doses of Lopinavir-Ritonavir Tablets.","volume":"Jul;55","author":"EH Decloedt","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","article-title":"Unexpected hepatotoxicity observed in a healthy volunteer study on the effects of multiple dose rifampicin on the steady-state pharmacokinetics of ritonavir-boosted sequinavir and vice versa.","year":"2005"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0b013e318189a7df","article-title":"Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.","volume":"Mar 1;50","author":"DW Haas","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/QAD.0b013e3282faa71e","article-title":"High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir\/ritonavir tablets.","volume":"May 11;22","author":"HM Nijland","year":"2008","journal-title":"AIDS"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.","volume":"Feb;45","author":"Z Desta","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1254\/jphs.FP0040296","article-title":"Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities.","volume":"Nov;96","author":"Y Nishimura","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"ref10","article-title":"Division of AIDS table for grading the severity of adult and paediatric adverse events.","year":"2004"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0b013e3181642257","article-title":"Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis.","volume":"Apr 15;47","author":"Y Ren","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/01.inf.0000180578.38584.da","article-title":"Pharmacokinetics and 24-week efficacy\/safety of dual boosted saquinavir\/lopinavir\/ritonavir in nucleoside-pretreated children.","volume":"Oct;24","author":"J Ananworanich","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref13","first-page":"4","article-title":"Updated guideline to perform therapeutic drug monitoring for antiviral agents.","volume":"3","author":"CJL la Porte","year":"2006","journal-title":"Rev Antivir Ther"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/QAD.0b013e328329148e","article-title":"Clinical experience with the combined use of lopinavir\/ritonavir and rifampicin.","volume":"Apr 27;23","author":"RF L'homme","year":"2009","journal-title":"AIDS"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T22:32:00Z","timestamp":1641076320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032173"}},"subtitle":[],"editor":[{"given":"Sarah","family":"Pett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,7]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032173","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,7]]}}}